Rein Therapeutics, Inc. (RNTX)
0.58
-0.03
(-5.23%)
USD |
NASDAQ |
Nov 06, 10:01
Rein Therapeutics Price : 0.58 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 0.65 | 0.655 | 0.5716 | 0.612 | 303903.0 |
| Nov 04, 2026 | 0.6877 | 0.7283 | 0.6537 | 0.6587 | 213895.0 |
| Nov 03, 2026 | 0.668 | 0.705 | 0.6340 | 0.6675 | 256431.0 |
| Nov 02, 2026 | 0.6898 | 0.7114 | 0.62 | 0.6354 | 392735.0 |
| Oct 30, 2026 | 0.70 | 0.70 | 0.66 | 0.67 | 121462.0 |
| Oct 29, 2026 | 0.7074 | 0.7495 | 0.6766 | 0.7266 | 189136.0 |
| Oct 28, 2026 | 0.697 | 0.7409 | 0.6600 | 0.7147 | 389886.0 |
| Oct 27, 2026 | 0.60 | 0.7199 | 0.5901 | 0.7042 | 622144.0 |
| Oct 26, 2026 | 0.57 | 0.6085 | 0.56 | 0.5832 | 394139.0 |
| Oct 23, 2026 | 0.595 | 0.6116 | 0.5718 | 0.5821 | 331333.0 |
| Oct 22, 2026 | 0.62 | 0.6244 | 0.59 | 0.6024 | 305247.0 |
| Oct 21, 2026 | 0.607 | 0.65 | 0.5951 | 0.6248 | 266088.0 |
| Oct 20, 2026 | 0.545 | 0.6072 | 0.5432 | 0.5951 | 296443.0 |
| Oct 19, 2026 | 0.5798 | 0.6150 | 0.5515 | 0.552 | 502154.0 |
| Oct 16, 2026 | 0.613 | 0.6219 | 0.5698 | 0.5903 | 372098.0 |
| Oct 15, 2026 | 0.60 | 0.666 | 0.551 | 0.628 | 1.373M |
| Oct 14, 2026 | 0.7546 | 0.755 | 0.5401 | 0.586 | 1.145M |
| Oct 13, 2026 | 0.7774 | 0.7774 | 0.7502 | 0.7546 | 142811.0 |
| Oct 12, 2026 | 0.77 | 0.7877 | 0.75 | 0.7849 | 108134.0 |
| Oct 09, 2026 | 0.7607 | 0.81 | 0.7607 | 0.794 | 307535.0 |
| Oct 08, 2026 | 0.784 | 0.784 | 0.7461 | 0.7693 | 477617.0 |
| Oct 07, 2026 | 0.80 | 0.8169 | 0.7802 | 0.7887 | 446970.0 |
| Oct 06, 2026 | 0.825 | 0.8341 | 0.8085 | 0.825 | 185635.0 |
| Oct 05, 2026 | 0.8148 | 0.8698 | 0.81 | 0.825 | 336292.0 |
| Oct 02, 2026 | 0.85 | 0.8634 | 0.78 | 0.8007 | 480883.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.89 |
| Alnylam Pharmaceuticals, Inc. | 157.02 |
| Anika Therapeutics, Inc. | 17.00 |
| Savara, Inc. | 4.56 |
| Vericel Corp. | 51.13 |
Price Related Metrics
| Price to Book Value | 4.877 |
| Earnings Yield | -296.2% |
| Market Cap | 49.74M |